Safety of iron polymaltose infusion given over 30 and 15 minutes for treatment of iron deficiency.
Phase 4
Completed
- Conditions
- Iron deficiency anaemia
- Registration Number
- ACTRN12617001615370
- Lead Sponsor
- Iouri Banakh
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method